Clinical Trials Webinar: Exploring Research and Insights Into Participation - Centre of Research Excellence in Pulmonary Fibrosis

We are pleased to share another new patient resource. In this webinar join expert speakers, A/Prof Vidya Navaratnam and Prof Ian Glaspole, to learn about pulmonary fibrosis clinical trials for pulmonary fibrosis including how trials work, recent research breakthroughs, and what’s involved in participation.

The webinar explores how clinical trials are conducted in stages. Phase 1 trials assess whether a new drug is safe. Phase 2 trials explore whether it works in people with the disease. Phase 3 trials involve larger groups to compare new treatments with standard care. Many studies also include an open-label extension, where all participants receive the study drug to assess long-term benefits and safety.

You will also learn about the PACT (Pulmonary Fibrosis Australasian Clinical Trials) Network, which also help patients find and access clinical trials across Australia, making it easier to explore new treatment options and support ongoing research in pulmonary fibrosis.

We produced this webinar in partnership with Lung Foundation Australia.

Pulmonary Fibrosis Institute

The Centre of Research Excellence in Pulmonary Fibrosis has established the Pulmonary Fibrosis Institute, a not-for-profit company registered in Australia. The Pulmonary Fibrosis Institute exists to support ongoing research into pulmonary fibrosis and ensure the longevity of research infrastructure developed through our collaborative efforts.